FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

Clinical Trial ID NCT00625404

PubWeight™ 22.96^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00625404

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Preexposure prophylaxis for HIV infection among African women.	N Engl J Med	2012	15.28
2	Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women.	AIDS	2015	1.10
3	Facilitators of adherence to the study pill in the FEM-PrEP clinical trial.	PLoS One	2015	0.94
4	An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women.	J Acquir Immune Defic Syndr	2016	0.82
5	Prevalence and incidence estimation of HSV-2 by two IgG ELISA methods among South African women at high risk of HIV.	PLoS One	2015	0.81
6	Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial.	BMC Pharmacol Toxicol	2014	0.79
7	siRNA-based topical microbicides targeting sexually transmitted infections.	Curr Opin Mol Ther	2010	0.79
8	Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention.	Pharm Pract (Granada)	2009	0.78
9	Sino-implant (II)® continuation and effect of concomitant tenofovir disoproxil fumarate-emtricitabine use on plasma levonorgestrel concentrations among women in Bondo, Kenya.	Contraception	2014	0.78
10	HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.	PLoS One	2011	0.78
11	Antiretroviral medication for preventing HIV infection in nonoccupational settings.	CMAJ	2012	0.75
12	Neurological syndrome in an HIV-prevention trial participant randomized to daily tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) in Bondo, Kenya.	Int Med Case Rep J	2013	0.75